πŸ‡ΊπŸ‡Έ FDA
Patent

US 9073980

Tumor selective E1a and E1b mutants

granted A61KA61K35/761A61K48/00

Quick answer

US patent 9073980 (Tumor selective E1a and E1b mutants) held by The Regents of the University of California expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/761, A61K48/00, A61P, A61P35/00